Thiochromene derivatives as HIF hydroxylase inhibitors
US9149476B2 · kind B2 · utility
7Cited by
49References
37Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 24, 2014 |
| Grant date | Oct 6, 2015 |
| Priority date | — |
| Expiry date | Dec 24, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel compounds, methods, and compositions capable of decreasing HIF hydroxylase enzyme activity, thereby increasing the stability and/or activity of hypoxia inducible factor (HIF).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.